Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Cancer Journal (Sudbury, Mass.)|September 23, 2024
Repurposing Drugs for Cancer Prevention: Targeting Mechanisms Common to Chronic DiseasesNirmal Choradia, Eva SzaboJournal for Immunotherapy of Cancer|February 28, 2019
Correction to: Treatment duration with immune-based therapies in Cancer: an enigmaShanta Bantia, Nirmal ChoradiaJournal for Immunotherapy of Cancer|December 7, 2018
Treatment duration with immune-based therapies in Cancer: an enigmaShanta Bantia, Nirmal ChoradiaJournal of the National Comprehensive Cancer Network : JNCCN|April 22, 2024
Health Care Lobbying and OncologyNirmal Choradia, Aaron Mitchell, Ryan NippCancer Prevention Research (Philadelphia, Pa.)|January 28, 2010
Assessing efficacy in early-phase cancer prevention clinical trials: the case of ki-67 in the lungEva SzaboEcancermedicalscience|December 5, 2015
Biomarkers in phase I-II chemoprevention trials: lessons from the NCI experienceEva SzaboNature Clinical Practice. Oncology|May 1, 2008
Primer: first do no harm--when is it appropriate to plan a cancer prevention clinical trial?Eva SzaboNature Reviews. Cancer|October 13, 2006
Selecting targets for cancer prevention: where do we go from here?Eva SzaboCancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Altered histology provides a positive clinical signal in the bronchial epitheliumEva SzaboPageof 23